+91 8744044044 / 8750295029
Global Pharma Network


Sorafenib is a kinase inhibitor drug approved for the treatment of primary kidney cancer (advanced renal cell carcinoma), advanced primary liver cancer (hepatocellular carcinoma), FLT3-ITD positive AML and radioactive iodine resistant advanced thyroid carcinoma.

Generic Version of Sorafenib Medicine

Query Form

Please fill in the details about your
medicine requirement on this form.

Global Pharma Network

60/4, T&T House. Yusuf Sarai.
New Delhi:110016 India.

Phone number

+91 8744044044



(Primary use: Liver Cancer)

Sorafenib (co-developed and co-marketed by Bayer and Onyx Pharmaceuticals as Nexavar) is used for (1) Treatment of advanced renal cell cancer (2) Hepatocellular carcinoma (HCC) (3) Thyroid cancer.

Sorafenib Price, Liver Cancer Treatment, Generic Sorafenib sold under the brand name in India
Sorafenib is used to treat Liver Cancer.

Details of Sorafenib Medication


Global Pharma Network can help you to provide access of Sorafenib medications sold under the brand name for Liver Cancer treatment by connecting Patients, Health Care Centers, Pharmacies and Retail Outlets with approved supplier, exporter and distributor of Generic drugs, innovator brands and biosimilar medicines from India. Call Mr. Tarun at +91 8744044044 for more details.

For Urgent Requirement "Sorafenib" Medication

Call at +91 9891296838 / 9811747774 for Sorafenib availability, Sorafenib Price and Sorafenib sold under the brand name. How to procure FDA approved Sorafenib Drugs for treatment of Liver Cancer in India and overseas?

Global Pharma

A Certified Pharmaceutical Wholesaler, Supplier, Exporters from India of FDA approved Sorafenib a targeted therapy drug sold under the brand name for treatment of Liver Cancer in India and overseas. We will help you in importing and exporting this medicine only upon the valid prescription of a licensed medical practitioner and other documents as required by the laws of the jurisdiction in which you are present. USA, UK, Russia, China, India, Nepal, Bhutan, Myanmar / Burma, Laos, Thailand, Cambodia, Hong Kong, Macau, Malaysia, Indonesia, Middle East, Japan, Philippines.


The information on the website is obtained through many different sources and the accuracy should be confirmed prior to use. The content of this website is not intended to be instructional for medical diagnosis or treatment. Always consult with your physician or qualified health care provider on medical issues.